Thursday, April 10, 2025
Pharmacology Preconference
Cardiovascular-Kidney-Metabolic Syndrome: Addressing Complex Interrelationships Among Obesity, Diabetes, CKD, and Heart Disease
- Describe mechanisms underlying the interplay among obesity, diabetes, chronic kidney disease and cardiovascular disease in cardiovascular-kidney-metabolic syndrome
- Identify the role of the cardiovascular nurse in the screening, staging and monitoring of cardiovascular-kidney-metabolic syndrome through a case study approach
- Discuss treatment guideline recommendations for patients with cardiovascular-kidney-metabolic syndrome
Menopausal Hormone Replacement Therapy
- Describe HRT and the common symptoms of menopause it aims to alleviate
- Discuss the impact of physiological changes during menopause and the effect of HRT on cardiovascular health
- Examine case study of real world application of HRT and how duration and dosage can impact cardiovascular health
Medical Marijuana: Understanding the Pharmacology
- Define cannabinoids and their pharmacotherapeutic use
- Discuss the pharmacokinetics of cannabinoids and the interactions with cardiac medications
- Identify the impact of cannabinoids on the cardiovascular system
Current Landscape of Cardiometabolic Clinical Trials: Lp(a), MASH, Diabetes/Obesity
- Define the significance of clinical trials in advancing treatment for cardio-metabolic diseases such as diabetes, hypertension, and dyslipidemia
- Describe the efficacy and safety profiles of emerging therapies based on current clinical trial data
- Discuss key components of designing robust cardio-metabolic clinical trials, including patient recruitment, patient diversity, endpoints, and the role of the CV nurse
General Sessions
Risk Assessment on the Horizon: Understanding Genetic Lipid abnormalities, screening, and treatments
- Discuss the role of genetic testing in screening for lipid abnormalities in individuals and families
- Review lipid treatment considerations including when to start lipid lowering therapies, treatment in special population (i.e. adolescents or pregnancy) and how to apply additional screening tools such as genetic testing or CACs
- Examine the impact of Lp(a) on CVD risk and treatment
- Explore the future of cardiovascular risk management and the role of the interdisciplinary team
Friday, April 11, 2025
Lifestyle Medicine: The Six Pillars
- Define lifestyle medicine and explain its importance in preventing, managing, and reversing chronic diseases
- Describe application of the six pillars of lifestyle medicine into clinical practice and patient care
- Discuss techniques for facilitating behavior change and motivating patients to adopt healthier lifestyles
Afib and Heart Failure: A deadly combination
- Describe how the coexistence of Afib and heart failure exacerbates each condition and contributes to worsened clinical outcomes
- Identify common risk factors and complications as well as patient populations at higher risk for each
- Discuss the current treatment guidelines and therapeutic options for managing Afib and heart failure
The Extraordinary Impact of Connection on Mental and Cardiovascular Health
- Describe four domains of connection (human, self, spirit, and senses) and their relationships to mental and cardiovascular health outcomes
- Examine the attributes of a therapeutic self
- Discuss specific connection practices nurses can cultivate within themselves and those they serve to promote healing and well-being
Hypertension: Local and Global Interventions
- Define the global and national prevalence and risk factors for hypertension highlighting the disproportionate impact on certain populations
- Discuss international and national guidelines for hypertension prevention, diagnosis, and management
- Examine successful population health initiatives to target hypertension prevention and control
Rural and Environment Health: A Cross Roads
- Explain the intersection of healthcare access, rural health and environmental health
- Explain the intersection of healthcare access, rural health and environmental health
- Discuss the impact of environmental factors on cardiovascular disease
Breakout: Cardiomyopathy Etiologies: HCM, ATTR and Oncology Treatment Toxicity
- Explain the physiology and types of cardiomyopathy on cardiovascular function
- Identify signs and symptoms of HCM, ATTR and Oncology treatment toxicity
- Discuss treatment and prevention strategies for worsening cardiomyopathy and heart failure
Breakout: PAD: An epidemic of poverty and race
- Describe the 2024 guidelines for treatment and management of lower extremity peripheral arterial disease recommendations
- Identify complications of PVD, such as critical limb ischemia, and develop plans for their prevention and management especially in high risk patient populations
- Discuss screening and assessment techniques to identify at risk populations to prevent or slow progression of PAD
Breakout: Aortic Stenosis: An increasing risk for structural heart disease
- Explain the pathophysiological mechanisms and symptoms leading to structural heart disease
- Describe the barriers and disparities to early identification and effective treatment for aortic stenosis
- Discuss current trends, emerging therapies, and advancements in the diagnosis and treatment of aortic stenosis such as AVR, TAVR and balloon valvuloplasty
Saturday, April 12, 2025
Food is Medicine
- Describe the principles of food as medicine and its relevance in cardiovascular disease management
- Discuss scientific evidence of food and dietary patterns in the prevention and management of CVD
- Utilize skills for assessing patients' nutritional status, providing individualized care planning and nutritional counseling techniques
Acute Coronary Syndrome: Prevention, Recognition and Treatment in the Lab or the OR
- Examine the causes and progression of cardiogenic shock
- Identify signs and symptoms of Acute Coronary Syndrome
- Discuss recent and upcoming advancements in open heart surgery and interventional cardiology
Partnering to Advocate for Improved Cardiovascular Health: It takes a team
- Define healthcare advocacy and recent successes in concerns in the field
- Describe the role of CV nurses as advocates for patients, communities and their nursing practice
- Apply team-based care concepts to enhancing access to healthcare for patients in the US
Accreditation Statement
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.
Visit our CE Library
Take a PCNA Continuing Education Course.
Take a Course »
Join us at an Event
We bring cutting edge information right to you.